Self-Assembled, Adjuvant/Antigen-Based Nanovaccine Mediates Anti-Tumor Immune Response against Melanoma Tumor

Malignant melanoma is a highly aggressive type of cancer that requires radical treatment strategies to inhibit the cancer cell progression and metastasis. In recent years, preclinical research and clinical trials on melanoma treatment have been considerably focused on the adjuvant-based immunotherap...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajendrakumar, Santhosh Kalash, Mohapatra, Adityanarayan, Singh, Bijay, Revuri, Vishnu, Lee, Yong-Kyu, Kim, Chang Seong, Cho, Chong-Su, Park, In-Kyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404041/
https://www.ncbi.nlm.nih.gov/pubmed/30960988
http://dx.doi.org/10.3390/polym10101063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404041/
https://www.ncbi.nlm.nih.gov/pubmed/30960988
http://dx.doi.org/10.3390/polym10101063

Ejemplares similares